NEW YORK ( TheStreet) -- Health stocks have been rallying. During the past year, the average health mutual fund returned 23.9%, while the S&P 500 gained 12.3%, according to Morningstar. Biotech stocks have been especially strong performers. With many companies winning drug approvals, Fidelity Select Biotechnology (FBIOX) returned 43.1% in the past year.Can the health stocks remain market favorites? Probably. The outlook for sales and earnings is strong. If President Obama wins reelection, his signature health reform legislation will proceed, offering insurance coverage to 30 million people. That will provide new customers for hospitals and pharmaceutical companies.
Health Care Funds That Can Continue Rallying
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.